JW (Cayman) Therapeutics Co. Ltd (2126.HK)

HKD 1.3

(0.0%)

Gross Profit Summary of JW (Cayman) Therapeutics Co. Ltd

  • JW (Cayman) Therapeutics Co. Ltd's latest annual gross profit in 2023 was 88.21 Million CNY , up 50.14% from previous year.
  • JW (Cayman) Therapeutics Co. Ltd's latest quarterly gross profit in 2024 Q2 was 43.74 Million CNY , down 0.0% from previous quarter.
  • JW (Cayman) Therapeutics Co. Ltd reported a annual gross profit of 58.75 Million CNY in annual gross profit 2022, up 549.6% from previous year.
  • JW (Cayman) Therapeutics Co. Ltd reported a annual gross profit of 9.04 Million CNY in annual gross profit 2021, down 0.0% from previous year.
  • JW (Cayman) Therapeutics Co. Ltd reported a quarterly gross profit of 44.81 Million CNY for 2023 Q2, down 0.0% from previous quarter.
  • JW (Cayman) Therapeutics Co. Ltd reported a quarterly gross profit of 88.21 Million CNY for 2023 FY, up 50.14% from previous quarter.

Annual Gross Profit Chart of JW (Cayman) Therapeutics Co. Ltd (2023 - 2018)

Historical Annual Gross Profit of JW (Cayman) Therapeutics Co. Ltd (2023 - 2018)

Year Gross Profit Gross Profit Growth
2023 88.21 Million CNY 50.14%
2022 58.75 Million CNY 549.6%
2021 9.04 Million CNY 0.0%
2020 - CNY -100.0%
2019 5.48 Million CNY 2450.23%
2018 215 Thousand CNY 0.0%

Peer Gross Profit Comparison of JW (Cayman) Therapeutics Co. Ltd

Name Gross Profit Gross Profit Difference
Uni-Bio Science Group Limited 392.81 Million HKD 77.542%
CK Life Sciences Int'l., (Holdings) Inc. 947.7 Million HKD 90.691%